These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21184855)

  • 1. Divergence of immunologic and protective responses of different BCG strains in a murine model.
    Kozak R; Behr MA
    Vaccine; 2011 Feb; 29(7):1519-26. PubMed ID: 21184855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
    Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
    Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence of BCG Pasteur in lungs of C57BL/6 mice following intranasal infection.
    Leversen NA; Sviland L; Wiker HG; Mustafa T
    Scand J Immunol; 2012 May; 75(5):489-99. PubMed ID: 22239126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis.
    Wedlock DN; Denis M; Vordermeier HM; Hewinson RG; Buddle BM
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):50-8. PubMed ID: 17524495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination.
    Connor LM; Harvie MC; Rich FJ; Quinn KM; Brinkmann V; Le Gros G; Kirman JR
    Eur J Immunol; 2010 Sep; 40(9):2482-92. PubMed ID: 20602436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
    Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection.
    Nambiar JK; Ryan AA; Kong CU; Britton WJ; Triccas JA
    Eur J Immunol; 2010 Jan; 40(1):153-61. PubMed ID: 19830735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination.
    Clark SO; Kelly DL; Badell E; Castello-Branco LR; Aldwell F; Winter N; Lewis DJ; Marsh PD
    Vaccine; 2010 Oct; 28(43):7109-16. PubMed ID: 20708695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.
    Haile M; Hamasur B; Jaxmar T; Gavier-Widen D; Chambers MA; Sanchez B; Schröder U; Källenius G; Svenson SB; Pawlowski A
    Tuberculosis (Edinb); 2005; 85(1-2):107-14. PubMed ID: 15687034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
    Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain.
    Aguilar D; Infante E; Martin C; Gormley E; Gicquel B; Hernandez Pando R
    Clin Exp Immunol; 2007 Feb; 147(2):330-8. PubMed ID: 17223975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity.
    Keyser A; Troudt JM; Taylor JL; Izzo AA
    Vaccine; 2011 Nov; 29(50):9308-15. PubMed ID: 22015391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic tracing and T cell responses following oral vaccination with live Mycobacterium bovis (BCG).
    Dorer DE; Czepluch W; Lambeth MR; Dunn AC; Reitinger C; Aldwell FE; McLellan AD
    Cell Microbiol; 2007 Feb; 9(2):544-53. PubMed ID: 17018037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.